nutbreak glp-1 patches – Infinity Hoop Abbey Sharp • Registered Dietitian

With their ability to control blood sugar levels, GLP-1s have also demonstrated positive impacts on weight loss and reduced cardiovascular risks

Potential implications of the new pharmacotherapies on obesity management The mean WL in clinical trials with the most efficacious new obesity pharmacotherapies ranges between 15% and 25% at 1 year (and it may be even higher for some agents that have not reached weight plateau at study completion)

Bagatin E, Costa CS

In March 2024, the FDA approved anti-obesity medication (AOM) semaglutide for reduction of the risk of serious heart problems like heart attack, stroke, and cardiovascular death in adults who have both heart disease (CVD) and are overweight or obese (1)

Tirzepatide (Mounjaro, Zepbound) Tirzepatide is a newer medication thats been making waves in the weight loss world

Review existing weight management programs and gaps Before launching something new, audit what benefits you already have in place: Do you have an evidence-based program for weight management